Juvederm Ultra 3 is a smooth, elastic hyaluronic acid dermal filler designed for the correction of moderate to deep facial wrinkles and enhancement of lips and facial contours. Its cohesive, monophasic gel structure ensures even distribution and natural results in dynamic facial zones. Formulated with 24 mg/ml of cross-linked HA and 0.3% lidocaine, it provides a balance of lift and softness, making it ideal for nasolabial folds, marionette lines, oral commissures, and lip definition.
The gel’s medium-high elasticity supports effective volumization while preserving natural facial expression. Developed with Hylacross™ technology, Juvederm Ultra 3 offers a consistent, long-lasting texture that allows for smooth extrusion and precise placement.
Results typically last 9–12 months, depending on the treatment area, technique, and patient metabolism.
Rheological properties / Product data
HA concentration: 24 mg/ml
Cross-linking agent: BDDE
Elasticity (G′): Medium-high
Cohesivity: Moderate
Texture: Monophasic, cohesive HA gel
Lidocaine content:0.3%
The filler’s rheological profile provides optimal balance between lift capacity and moldability, allowing controlled shaping of facial contours and smooth correction of deeper lines.
Injection depth & tools
Recommended depth: Mid to deep dermis or subcutaneous layer
Injection techniques: Linear threading, fan, or cross-hatching technique
Recommended instruments: 27G needle or 25G cannula (depending on target area)
Inject slowly under aseptic conditions. Always aspirate before injection to minimize risk of intravascular events. Avoid overcorrection.
Storage & handling
Store at 2°C–25°C, away from sunlight and moisture
Do not freeze or heat
Single-use only — discard any unused material immediately
Dispose of syringes and needles in accordance with local medical waste regulations
For use by licensed medical professionals only. Not intended for self-administration.
Common reactions: mild redness, swelling, tenderness, or bruising at the injection site, which usually resolve within a few days. Serious but rare complications may include vascular occlusion, blanching, or visual impairment — immediate medical attention is required. Post-procedure cold compresses and gentle aftercare help minimize local reactions.
Patients should avoid alcohol for at least 24 hours before and after injection, as vasodilation may increase bruising or swelling.
Use during pregnancy is not recommended. No clinical trials confirm safety for pregnant patients. Elective procedures should be postponed until after childbirth.
Dermal filler treatments are not advised during breastfeeding, as excretion of metabolites into breast milk has not been studied. Procedures should be delayed until after lactation ends.
Inject into the mid to deep dermis using linear threading or fan technique, depending on the correction area. Typical treatment volume ranges between 0.5–1.0 ml per side, but dosage should be individualized based on clinical assessment.
The cross-linked hyaluronic acid binds water molecules within the dermis, restoring lost volume and hydration. Its monophasic cohesive matrix ensures uniform integration into tissue, maintaining elasticity and smooth palpation over time. The filler gradually biodegrades without residue, leaving skin naturally refreshed and firm.
Contains cross-linked hyaluronic acid (24 mg/ml) of non-animal origin, stabilized with BDDE, and combined with lidocaine (0.3%) to minimize injection discomfort. The formulation’s structure provides durable correction with a soft, natural feel.
